赵岩医生简介

辽宁省肿瘤医院 副院长，医学博士，主任医师，博士研究生导师。二级心理咨询师、临床营养师
主要研究方向：消化道肿瘤的手术、化疗及靶向治疗、消化道肿瘤的发生、遗传学及其临床意义、胃肠间质瘤的综合诊治、肿瘤营养等。
工作内容：胃部肿瘤的诊断和以手术为主的综合治疗。胃肠道间质瘤的诊断和综合治疗。遗传学咨询、临床营养及心理咨询。

中华医学会肿瘤医学分会胃癌学组 委员
中国临床肿瘤学会CSCO胃癌专家委员会 委员
中国临床肿瘤学会CSCO胃肠间质瘤专家委员会 委员
中国临床肿瘤学会CSCO肿瘤大数据专家委员会 常委
中国医师协会外科分会胃肠间质瘤专业委员会 常委
中国医师协会科研出版工作委员会 常委
中国医师协会外科医师分会胃肠道间质瘤诊疗专业委员会 常委
中国抗癌协会青年理事会 常务理事
中国抗癌协会癌症筛查与早诊早治专业委员会 常务委员
中国抗癌协会胃肠间质瘤专业委员会 常委
中国抗癌协会肿瘤支持治疗专业委员会 委员 
中国医院协会互联网健康专业委员会 委员
中国卫生信息与健康医疗大数据学会 常务委员
国家远程医疗与互联网医学中心医疗5G网络建设工作委员会 副主任委员

2018年，中国医师协会，人文医师
2020年，辽宁省科协，优秀科技工作者
2020年，辽宁省电视台，都市频道，名优主讲专家
2021年，抗击疫情先进分子

1. Oda, S., et al., Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability. Nucleic Acids Res, 2005. 33(5): p. 1628-36.
2. Oda, S., Y. Zhao, and Y. Maehara, Microsatellite instability in gastrointestinal tract cancers: a brief update. Surg Today, 2005. 35(12): p. 1005-15.
3. Sakurai, M., et al., High-resolution fluorescent analysis of microsatellite instability in gastric cancer. Eur J Gastroenterol Hepatol, 2007. 19(8): p. 701-9.
4. Zhao, Y., et al., Exclusive KRAS mutation in microsatellite-unstable human colorectal carcinomas with sequence alterations in the DNA mismatch repair gene, MLH1. Gene, 2008. 423(2): p. 188-93.
5. Oki, E., et al., Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Ann Surg Oncol, 2009. 16(9): p. 2510-5.
6. Oki, E., et al., The difference in p53 mutations between cancers of the upper and lower gastrointestinal tract. Digestion, 2009. 79 Suppl 1: p. 33-9.
7. Oki, E., et al., Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer. World J Gastroenterol, 2009. 15(20): p. 2520-5.
8. Ando, K., et al., High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer. Cancer Sci, 2010. 101(3): p. 639-45.
9. Zhao, Y., et al., The impact of a high-frequency microsatellite instability phenotype on the tumor location-related genetic differences in colorectal cancer. Cancer Genet Cytogenet, 2010. 196(2): p. 133-9.
10. Ando, K., et al., Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: report of a case. Surg Today, 2011. 41(9): p. 1290-3.
11. Yoshida, R., et al., Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer. Eur J Hum Genet, 2011. 19(3): p. 320-5.
12. Liang, J.W., et al., Laparoscopic versus open gastric resections for gastric gastrointestinal stromal tumors: a meta-analysis. Surg Laparosc Endosc Percutan Tech, 2013. 23(4): p. 378-87.
13. Nakanishi, R., et al., Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer. Int J Clin Oncol, 2013. 18(6): p. 1042-8.
14. Zhang, J., et al., The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells. Clin Exp Med, 2013. 13(4): p. 323-8.
15. Zhao, Y., et al., GSTT1 null genotype contributes to increased risk of gastric cancer in Chinese population: evidence from a meta-analysis. Tumour Biol, 2013. 34(3): p. 1691-7.
16. Ando, K., et al., Mortalin is a prognostic factor of gastric cancer with normal p53 function. Gastric Cancer, 2014. 17(2): p. 255-62.
17. Zhao, Y., et al., Aberrations of BUBR1 and TP53 gene mutually associated with chromosomal instability in human colorectal cancer. Anticancer Res, 2014. 34(10): p. 5421-7.
18. Yu, T., et al., Prediction of T stage in gastric carcinoma by enhanced CT and oral contrast-enhanced ultrasonography. World J Surg Oncol, 2015. 13: p. 184.
19. Zhao, Y., et al., Low-frequency microsatellite instability in genomic di-nucleotide sequences correlates with lymphatic invasion and poor prognosis in gastric cancer. Cell Biochem Biophys, 2015. 71(1): p. 235-41.
20. Eto, T., et al., Modal variety of microsatellite instability in human endometrial carcinomas. J Cancer Res Clin Oncol, 2016. 142(2): p. 353-63.
21. Zheng, G.L., et al., [Analysis of the therapeutic efficacy of radical gastrectomy in Siewert type and adenocarcinoma of the esophagogastric junction]. Zhonghua Zhong Liu Za Zhi, 2016. 38(7): p. 538-42.
22. Zhu, H., et al., Anticancer effect of 2,7-dihydroxy-3-methylanthraquinone on human gastric cancer SGC-7901 cells in vitro and in vivo. Pharm Biol, 2016. 54(2): p. 285-92.
23. Zhang, B., et al., Clinicopathological characteristics and prognosis of primary appendiceal stromal tumors. World J Surg Oncol, 2018. 16(1): p. 225.
24. Zhang, J., et al., Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis. World J Gastroenterol, 2018. 24(43): p. 4906-4919.
25. Zheng, G.L., et al., [Clinical value of endoscopicultrsaonography and multi-slice spiral CT in Siewert and type adenocarcinoma of esophagogastric junction]. Zhonghua Zhong Liu Za Zhi, 2018. 40(3): p. 191-195.
26. Jiang, H., et al., Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis. Pathol Res Pract, 2019. 215(10): p. 152569.
27. Meng, X., et al., Neoadjuvant Chemoradiation Treatment for Resectable Esophago-Gastric Cancer: A Systematic Review and Meta-Analysis. J Cancer, 2019. 10(1): p. 192-204.
28. Meng, X., et al., Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer. Exp Ther Med, 2019. 18(3): p. 2219-2230.
29. Wang, Y., et al., Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis. Clin Transl Oncol, 2019. 21(11): p. 1499-1509.
30. Xu, X., et al., Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response. Cancer Chemother Pharmacol, 2019. 84(3): p. 635-646.
31. Zhang, J., et al., ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1. J Physiol Biochem, 2019. 75(3): p. 379-389.
32. Zhang, J., et al., P4HB, a Novel Hypoxia Target Gene Related to Gastric Cancer Invasion and Metastasis. Biomed Res Int, 2019. 2019: p. 9749751.
33. Zhang, J., et al., Hypoxia-induced LncRNA PCGEM1 promotes invasion and metastasis of gastric cancer through regulating SNAI1. Clin Transl Oncol, 2019.
34. Dong, Z., et al., USP19 Enhances MMP2/MMP9-Mediated Tumorigenesis in Gastric Cancer. Onco Targets Ther, 2020. 13: p. 8495-8510.
35. Dong, Z., et al., Identification of Hub Genes in Gastric Cancer with High Heterogeneity Based on Weighted Gene Co-Expression Network. Crit Rev Eukaryot Gene Expr, 2020. 30(2): p. 101-109.
36. Meng, X., et al., Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma. Biomed Res Int, 2020. 2020: p. 8657468.
37. Tong, Y., et al., Tumor Regression Grade Predicts Survival in Locally Advanced Gastric Adenocarcinoma Patients with Lymph Node Metastasis. Gastroenterol Res Pract, 2020. 2020: p. 3435673.
38. Wang, Y., et al., A SEER population analysis of stage IB resected gastric cancer: who can benefit from adjuvant therapy? Scand J Gastroenterol, 2020. 55(2): p. 193-201.
39. Wang, Y., et al., Indications of neoadjuvant chemotherapy for locally advanced Gastric Cancer patients based on pre-treatment clinicalpathological and laboratory parameters. J Cancer, 2020. 11(20): p. 6000-6008.
40. Yang, D., et al., Patient-generated subjective global assessment versus nutritional risk screening 2002 for gastric cancer in Chinese patients. Future Oncol, 2020. 16(3): p. 4475-4483.
41. Zhang, J., et al., LINC00163 inhibits the invasion and metastasis of gastric cancer cells as a ceRNA by sponging miR-183 to regulate the expression of AKAP12. Int J Clin Oncol, 2020. 25(4): p. 570-583.
42. Zhang, T., et al., LncRNA PCGEM1 enhances metastasis and gastric cancer invasion through targeting of miR-129-5p to regulate P4HA2 expression. Exp Mol Pathol, 2020. 116: p. 104487.
43. Zheng, G., et al., Clinicopathological Features, Treatment Strategy, and Prognosis of Primary Non-Hodgkin's Lymphoma of the Duodenum: A SEER Database Analysis. Can J Gastroenterol Hepatol, 2020. 2020: p. 9327868.
44. Cui, H., et al., Chemotherapeutic potency stimulated by SNAI1-knockdown based on multifaceted nanomedicine. J Control Release, 2021. 337: p. 343-355.
45. Guo, S., et al., The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer. Asia Pac J Clin Oncol, 2021. 17(2): p. e117-e124.
46. Meng, X., et al., Totally Laparoscopic Gastrectomy Versus Laparoscopic-Assisted Gastrectomy for Gastric Cancer: A Systematic Review and Meta-Analysis. J Laparoendosc Adv Surg Tech A, 2021. 31(6): p. 676-691.
47. Tong, Y., et al., Evaluation and Comparison of Predictive Value of Tumor Regression Grades according to Mandard and Becker in Locally Advanced Gastric Adenocarcinoma. Cancer Res Treat, 2021. 53(1): p. 112-122.
48. Wang, Y., et al., What is behind the fear of cancer during menopausal hormone therapy in China? Arch Gynecol Obstet, 2021.
49. Zheng, G.L., et al., Surgical resection of esophagogastric junction stromal tumor: How to protect the cardiac function. World J Gastroenterol, 2021. 27(9): p. 854-865.